key: cord-0804305-lpbk8apa
authors: Zhu, Chaogeng; He, Guiyun; Yin, Qinqin; Zeng, Lin; Ye, Xiangli; Shi, Yongzhong; Xu, Wei
title: Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge
date: 2021-06-14
journal: J Med Virol
DOI: 10.1002/jmv.27132
sha: 9053d265cf98487a4ae0feda9599b63937352e7f
doc_id: 804305
cord_uid: lpbk8apa

The global coronavirus disease 2019 (COVID‐19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has led to an unprecedented worldwide public health emergency. Despite the concerted efforts of the scientific field, by April 25, 2021, SARS‐CoV‐2 had spread to over 192 countries/regions, causing more than 146 million confirmed cases including 31 million deaths. For now, an established treatment for patients with COVID‐19 remains unavailable. The key to tackling this pandemic is to understand the mechanisms underlying its infectivity and pathogenicity. As a predominant focus, the coronavirus spike (S) protein is the key determinant of host range, infectivity, and pathogenesis. Thereby comprehensive understanding of the sophisticated structure of SARS‐CoV‐2 S protein may provide insights into possible intervention strategies to fight this ongoing global pandemic. Herein, we summarize the current knowledge of the molecular structural and functional features of SARS‐CoV‐2 S protein as well as recent updates on the cell entry mechanism of the SARS‐CoV‐2, paving the way for exploring more structure‐guided strategies against SARS‐CoV‐2.

The ongoing coronavirus disease 2019 (COVID-2019) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to an unprecedented worldwide public health emergency. Despite the concerted efforts of the scientific field, as of April 25, 2021 , more than 146 million confirmed cases including 31 million death were reported from around 192 countries/regions all over the world (https://coronavirus.jhu.edu/map.html). For now, established treatment for patients with COVID-19 remains unavailable. Thereby scientific insights and in-depth understanding of the biology and pathogenesis of the virus are imperative for deciphering its mystery and curbing its spread. As a predominant focus, coronavirus spike (S) protein plays an essential role in coronavirus infection, pathogenicity, transmission, and evolution. 1 Changes in just a few residues around the spike protein can dramatically affect the infectivity, tropism, and pathogenesis of the virus. [2] [3] [4] Furthermore, potential adaptive mutations in the SARS-CoV-2 genome possibly make it highly pathogenic and difficult for drug or vaccine development. In this review, we summarize the current knowledge of the molecular structural and functional features of SARS-CoV-2 S protein as well as recent updates on the cell entry mechanism of the SARS-CoV-2, providing insights into virus pathogenesis, vaccine design, and drug target.

Coronaviruses (CoVs), currently the largest known genome size for RNA virus, are enveloped viruses with positive single-stranded RNA genomes ranging from 26 to 32 kb in length. 5 The coronaviruses are broadly classified into four genera as alpha, beta, gamma, and delta, 6 α-CoVs and β-CoVs primarily infecting mammals, 7, 8 whereas γ-CoVs and δ-CoVs predominantly infect birds. 9, 10 To date, seven coronaviruses are known to infect humans (hCoVs)

including HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, MERS-CoV, SARS-CoV, and SARS-CoV-2 have so far been identified (Table S1 ). [11] [12] [13] The former four hCoVs were known to cause just mild clinical symptoms. 14 However, the latter three hCoVs are highly pathogenic, causing relatively severe respiratory disease and high mortality. 15, 16 SARS-CoV-2 exhibits 79.9% sequence identity to SARS-CoV at the whole genome level and clusters with SARS-CoV in phylogenetic analysis ( Figure 1A ). Further comparison and analysis of the spike (S) gene of the seven hCoVs revealed that the genetic divergence of the S genes is consistent with that of the full-length genomes ( Figure 1B , Table S2 ). SARS-CoV-2 belongs to Beta-CoVs B lineage closely related to SARS-CoV and SARS-related bat CoVs. 17, 18 Although conclusive evidence is lacking, distinctive phylogenetic distances on the major clade of SARS-CoV-2 provided a clue to the evolutionary relationships among them. 17 Sequence analysis at fulllength genome level showed that SARS-CoV-2 is much closer to the bat CoV RaTG13 (96.2% identical) than to SARS-CoV (79.5% identical). In addition, although Zhou et al. 19 reported a bat-derived coronavirus named RmYN02 from Rhinolophus malayanus sharing 93 .3% identity with SARS-CoV-2 in the complete genome, RmYN02 has a low sequence identity (61.3%) with SARS-CoV-2 in the Receptor Binding Domain (RBD). However, the RaTG13 was found to have an 89% RBD identical to SARS-CoV-2, indicating a bat origin.

The genome of SARS-CoV-2 is approximately 29.7 kb in size, encoding four major structural proteins, including spike (S), nucleocapsid (N), membrane (M), and envelope (E), and 16 nonstructural proteins. 20 The full-length of SARS-CoV-2 S is 1273 amino acid long with several functional domains and multiple proteolytic cleavage sites at S1/S2 boundary and S2' site ( Figure 2B ). The spike protein (S) of SARS-CoV-2 is a trimeric class I fusion protein containing two subunits: S1 and S2, which remain noncovalently bound in a prefusion metastable conformation 23, 24 protruding from the viral surface as a complete homotrimer and forming the distinctive surface spikes of coronaviruses. 25 The S protein of SARS-CoV-2 and SARS-CoV have about 74.0% identity at amino acid level. A breakdown of the functional domains of the SARS-CoV-2 S, based on F I G U R E 1 Phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other hCoVs. (A) Full-length genome phylogenetic tree of 7 hCoVs; (B) phylogenetic tree of the S gene of 7 hCoVs. Nucleotide sequences of the full-length genome/S genes were aligned respectively using MEGA 7 and iTOL online software. Maximum likelihood trees were constructed by using 1000 bootstraps. Respective sequences were obtained from NCBI with indicated accession numbers (SARS-COV-2, NC_045512; SARS-COV, NC_004718.3, MERS-COV, NC_019843.3; hCoV-OC43, NC_006213.1; hCoV-HKU1, NC_006577.2; hCoV-NL63, NC_005831.2; and hCoV-229E, NC_002645.1). The phylogenetic trees of the full-length genome/Spike gene of SARS-Cov-2 were made using iTOL online software . The data (The listed domain boundaries of the SARS-CoV-2 S and SARS-COV S) were derived from the following resources available at (DOI: 10.1038/s41423-020-0374-2). 21 (C) Schematic drawing of the threedimensional (3D) structure of SARS-CoV-2 S; (D) Single monomer from the trimeric SARS-CoV-2 S (PDB ID: 6VSB-1, Represented by Chain A). 22 (E) Trimeric SARS-CoV-2 spike protein (PDB ID: 6VSB), 22 three monomers are shown (magenta, green and cyan). These data that support the findings of this study are openly available in (PDB) at (https://www1.rcsb.org/) 22 | 5731 SARS-CoV S sequence, reveals that the S1 subunit was quite variable (63.3% identity) ( Figure S1 ), such observations are in line with previous reports that the S1 is the most variable region of the molecule, both across and within the four CoVs genera. 26 However the S2 subunit is remarkably much more conserved (90.0% identity). With such both varied and conserved domains, the spike protein plays a pivotal role in the biology and pathogenesis of SARS-CoV-2 corresponding to their sophisticated structures (Table 1 ).

Structurally, the S1 subunit is made up of two main domains: . 34 These data that support the findings of this study are openly available in (PDB) at (https://www1.rcsb.org/) 34 acid residues, is longer than all linear GBD characterized to date.

It's fully conserved among worldwide clinical isolates and may facilitate contact with ACE2 receptor. 36 The RBD, as a key element of the CTD in SARS-CoV-2, consists of two motifs: a core structure and an extended loop, the latter also known as a receptor-binding motif (RBM). The core is a twisted fivestranded anti-parallel β sheet (β1, β2, β3, β4, and β7), with three short helices (α1, α2, and α3); The RBM, formed by a two-stranded β sheet (β5 and β6), lies at one edge of the core and contains most of the contacting residues binding to hACE2 30 ( Figure 4A ). Homology modeling between SARS-CoV-2 and SARS-CoV has shown that both the overall RBD structure model and the RBD-ACE2 binding model are strikingly similar 5,30 ( Figures 4B,C) . Even in the more variable RBM (45.7% identity), the overall structure is still highly similar. 30 In others words, most amino acid residues that are critical for hACE2

binding are highly conserved in SARS-CoV-2 ( Figure 4A ). RBD-ACE2

binding affinity has been shown to be a crucial element determining the infectivity of SARS-CoV. 37 Despite the nearly identical structure are critical for SARS spike binding, 40 and regulate the infectivity, pathogenesis, and cross-species transmissions of SARS-CoV. 41, 42 The SARS-CoV-2 RBM has evolved to stabilize the two hotspots with Gln493 and Leu455 stabilizing hotspot Lys31, whereas Asn501 stabilizing hotspot Lys353 ( Figure 4A ), contributing to considerable stabilization and higher affinity for RBD-ACE2 binding. 39 (iii) Six key residues (L455, F486, Q493, S494, N501, and Y505) in RBD of SARS-CoV-2 S, which correspond to Y442, L472, N479, D480, T487, and Y491 in SARS-CoV S, have been shown to be critical for receptor binding as well as cross-species transmission of SARS-CoV-2. 37 Five out of these six key residues differ between them. ( Figure 4A ).

Among them, L455, F486, Q493, and S494 in SARS-CoV-2 were revealed to provide favorable recognition and interactions with hACE2, hence enhancing viral binding, while N501 recognizes hACE2 more efficiently than that of SARS-CoV S, which increased SARS-CoV-2 infectivity. 37 Paradoxically, despite the extraordinary potency of its RBD binding affinity, the overall binding ability of SARS-CoV-2 S is comparable or even lower than that of SARS-CoV S. 43 Cryo-electron microscopy at the atomic level revealed different conformations of the homo-trimeric SARS-CoV-2 S with both "open" (receptoraccessible) and "close" (receptor-accessible) states. In the "close" state all the three RBDs are tightly packed together, while in the "open" state, the SARS-CoV-2 S was conformed in an asymmetric conformation in which one RBD was in "up" state whereas the other two in "down" state, 22, 27 or two RBDs in "up" while the other one in "down" state. 44, 45 Cryo-EM structure studies revealed that the RBD in SARS-CoV S is mostly in "up" state, 46, 47 while the RBD in SARS-CoV-2 S is mostly in "down" state. 22, 27 Therefore, although SARS-CoV-2 RBD has stronger hACE2 binding affinity, it is less accessible, resulting in comparable or even lower overall binding ability compared to SARS-CoV. ( Figure S1 ).

The FP ( 788 IYKTPPIKDFGGFNFSQIL 806 ), located at a site immediately upstream S2′, is biochemically characterized by its hydrophobic nature owing to its abundance of hydrophobic residues. The potential lipids-binding residues in FP of SARS-CoV-2 is centralized amid in Lys790, Thr791, Lys795, Asp808, and Gln872 residues, contributing to lipid interaction and penetration. 48 Surface models predicted that the FP of SARS-CoV-2 S was organized in a more compact conformation than that of SARS-CoV S. 49 Cleavage at S2′ exposes the FP domain, which, in turn, inserted in the host membrane triggering the viral fusion. 22 With strong membrane-perturbing capacities, 50 FP plays a crucial role in cell fusion. 31 With a stretch of 24 hydrophobic amino acid residues, the transmembrane domain (TM), which anchors the spike protein to the viral membrane, has been shown to be crucial for spike protein trimerization and membrane fusion. 32 It is hypothesized that the TM (anchored in the viral envelope) interacts with the FP (partitioned in the host membrane) to facilitate formation of the fusion pore. 54 The S2 subunit ends with a CD tail, which contains a palmitoylated cysteine-rich region (of 36 residues with 8 cysteines) and comprises the intracellular short tail part. Located at the C-terminal of the S protein and the inner side of the cell membrane, CD is reported to be involved in viral assembly, intracellular transport, and cell-cell fusion. 33 

For SARS-CoV-2 to enter host cells, besides host cell receptor binding, priming and activation of the spike protein by host proteases is another crucial event modulating tropism and pathogenicity. 55 "Priming" occurs at S1/S2 boundary providing the SARS-CoV-2 S protein with the structural flexibility required for separating S1 and S2. 56 And a subsequent "activation" cleavage at S2´site generates the exposure of FP and its insertion into the membrane. 57 for RBD-hACE2 binding. 56 A Furin cleavage motif insertion at the S1/ S2 junction of SARS-CoV enhances spike-driven cell to cell fusion. 66 However blockade of the Furin cleavage motif in SARS-CoV-2 affected its entry into the TMPRSS2 + human lung cell line Calu-3. 60 Collectively, the Furin-like motif provides SARS-CoV-2 with a gainof-function for more efficient transmission in human, reducing its dependence on host cell proteases for entry and expanding its entry into multi-type of cells. 43 70 Proteolytic activation at the S2′ site anchored spike proteins in the target cells membrane, eventually leading to early fusion at the cytoplasmic membrane. 23 This process has been proposed to activate the spike protein with irreversible conformational changes and trigger the membrane fusion activity. 64 TMPRSS2 is also essential for SARS-CoV-2 to enter human lung cells. 59 F I G U R E 5 Amino acid residues at the S1/S2 border and S2′site among different coronavirus spike proteins. Mono-and multibasic motifs suitable for host cell protease-mediated cleavage are highlighted with red bold; red asterisks indicate canonical Furin-like cleavage motif at the S1/S2 boundary in different coronavirus how SARS-CoV-2 enters human cells is a high priority for deciphering its mystery and curbing its spreading.

Evidence that SARS-CoV-2 utilizes host ACE2 (hACE2) as a critical receptor for cell entry is now strong and convincing, 17, 30, 37, 59, 81 which is strikingly similar to the mechanism exploited by SARS-CoV. 82 ACE2 is ubiquitously expressed in human tissues with high levels in the heart, vessels, kidneys, brain, lung, and so forth. 89 As an endogenous counter-regulator of the renin-angiotensin system (RAS) and a cell-surface peptidase that hydrolyzes angiotensin I to angiotensin 1-9 and angiotensin II to angiotensin 1-7. ACE2 plays a vital role in the maintenance of the cardiovascular system, as well as in renal, intestinal, and respiratory systems. 90 

It is now well established that SARS-CoV-2 utilizes the host ACE2

receptor to gain host cell entry. 59, 80 But SARS-CoV-2 seems to infect a diverse range of cell types, 96 and ACE2 is widely expressed across a variety of organs. The lung, with only moderate but not the highest expression of ACE2, 97 however, is the major infected organ. Furthermore, the unique Furin motif at S1/S2 and dibasic cleavage S2′ site may allow SARS-CoV-2 to undergo virus-cell fusion (receptorindependent entry) as well as cell-cell fusion. 98 the hypothesis that CD147/BSG acts as a coreceptor or an equally essential new receptor remains to be well established.

Glucose Regulated Protein 78 (GRP78), also known as BiP or HSPA5, was indicated by accumulated proof to be another receptor for SARS-CoV-2 cell entry. [104] [105] [106] [107] [108] Four regions of the SARS-CoV-2 Spike protein were predicted by molecular docking to bind the host cell surface GRP78. 104 Palmeira et al. 108 found preliminary evidence that further proposed GRP78 as a possible molecular target to inhibit SARS-CoV-2 infection. The same proposition has confirmed by Allam et al., 107 who identified nine compounds that could act as potential blockers of SARS-CoV-2 cell entry through GRP78.

Nevertheless, although the model study confirmed that SARS-CoV-2 S could stably interact with the GRP78, the structure of SARS-CoV-2 S this study relied on differs from the previously published structure obtained by cryo-EM. 22 Further mechanistic studies, as well as the role of GRP78 as entry receptor in SARS-CoV-2 infection, remain to be demonstrated.

F I G U R E 6 Hypothesized mechanism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry. The SARS-CoV2 S engages with the hACE2 receptor and is subsequently cleaved at S1/S2 and S2′ sites by proteases including, but not limit to, Furin, TMPRSS2, and cathepsin L. This leads to activation of the S2 and the forming of fusion core, ultimately drives membrane fusion and the release of viral RNA into host cell ZHU ET AL. contacts host ACE2 with striking differences compared to SARS-CoV. 30 The overall interaction between SARS-CoV-2 S and hACE2, however, remains to be elucidated. Future research will shed light on the biological features as well as the mechanism of SARS-CoV-2 infection.

This study was supported by funds from the COVID-19 Special 20200477). We thank Yun Deng for technical guidance.

Ready, set, fuse! The coronavirus spike protein and acquisition of fusion competence

The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity

Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus

Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China

Canine enteric coronaviruses: emerging viral pathogens with distinct recombinant spike proteins

Diagnosis of feline infectious peritonitis: a review of the current literature

Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition

Discovery of seven novel mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus

Coronaviruses post-SARS: update on replication and pathogenesis

Middle East respiratory syndrome (MERS): a new zoonotic viral pneumonia

Coronaviruses: important emerging human pathogens

Hosts and sources of endemic human coronaviruses

SARS-associated coronavirus

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A new coronavirus associated with human respiratory disease in China

A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein

SARS-CoV-2-A tough opponent for the immune system

Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer

Structural insights into coronavirus entry

The molecular biology of coronaviruses

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

SARS-CoV-2 and COVID-19: a genetic, epidemiological, and evolutionary perspective

Characterization of the receptorbinding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Fusion peptide from influenza hemagglutinin increases membrane surface order: an electron-spin resonance study

The role of the transmembrane and of the intraviral domain of glycoproteins in membrane fusion of enveloped viruses

Genetic analysis of the SARS-coronavirus spike glycoprotein functional domains involved in cell-surface expression and cell-to-cell fusion

COVID-19 pandemic: insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2

Sialic acid receptors of viruses

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection

Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decadelong structural studies of SARS coronavirus

Emerging coronaviruses: genome structure, replication, and pathogenesis

Structural basis of receptor recognition by SARS-CoV-2

A virus-binding hot spot on human angiotensin-converting enzyme 2 is critical for binding of two different coronaviruses

Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections

Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus

Cell entry mechanisms of SARS-CoV-2

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Structureguided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

In silico structure-based repositioning of approved drugs for spike glycoprotein S2 domain fusion peptide of SARS-CoV-2: rationale from molecular dynamics and binding free energy calculations. mSystems

Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop

Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/ 18-mer peptide scan: implications for the viral fusion mechanism

Wild-type and mutant hemagglutinin fusion peptides alter bilayer structure as well as kinetics and activation thermodynamics of stalk and pore formation differently: mechanistic implications

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

The spike protein of SARS-CoV-a target for vaccine and therapeutic development

HIV-1 gp41 transmembrane domain interacts with the fusion peptide: implication in lipid mixing and inhibition of virus-cell fusion

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

Evolution of SARS-CoV-2 spike glycoprotein

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Mechanisms of coronavirus cell entry mediated by the viral spike protein

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells

Furin-mediated protein processing in infectious diseases and cancer

The proteolytic regulation of virus cell entry by furin and other proprotein convertases

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Host cell proteases: critical determinants of coronavirus tropism and pathogenesis

Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism

Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry

Role of hemagglutinin cleavage for the pathogenicity of influenza virus

Structures and dynamics of the novel S1/S2 protease cleavage site loop of the SARS-CoV-2 spike glycoprotein

SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

Why are RNA virus mutation rates so damn high?

Epidemiology, genetic recombination, and pathogenesis of coronaviruses

Variant analysis of SARS-CoV-2 genomes

Mutational frequencies of SARS-CoV-2 genome during the beginning months of the outbreak in USA

Human SARS CoV-2 spike protein mutations

Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding

An updated analysis of variations in SARS-CoV-2 genome

Structure, function, and evolution of coronavirus spike proteins

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues

Structure of SARS coronavirus spike receptor-binding domain complexed with receptor

Priming time: how cellular proteases arm coronavirus spike proteins. Activation of Viruses by Host Proteases

Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion

Viral membrane fusion

Membrane insertion of the three main membranotropic sequences from SARS-CoV S2 glycoprotein

A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxypeptidase

The angiotensin converting enzyme 2 (ACE2), gut microbiota, and cardiovascular health

Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig

Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy

Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the reninangiotensin system

Novel ACE2-independent carbohydrate-binding of SARS-CoV-2 spike protein to host lectins and lung microbiota

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection

SARS-CoV-2 invades host cells via a novel route: CD147-spike protein

Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

COVID-19 and genetic variants of protein Involved in the SARS-CoV-2 entry into the host cells

Longitudinal analyses reveal immunological misfiring in severe COVID-19

COVID-19 spike-host cell receptor GRP78 binding site prediction

The stress-inducible molecular chaperone GRP78 as potential therapeutic target for coronavirus infection

Molecular docking analysis of Withaferin A from Withania somnifera with the Glucose regulated protein 78 (GRP78) receptor and the SARS-CoV-2 main protease

Targeting the GRP78-dependant SARS-CoV-2 cell entry by peptides and small molecules

Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection

KIM-1/TIM-1 is a receptor for SARS-CoV-2 in lung and kidney

KIM-1-mediated phagocytosis reduces acute injury to the kidney

Kidney injury molecule-1 is a potential receptor for SARS-CoV-2

The authors declare that there are no conflict of interests.